Aptevo Therapeutics (APVO) Filings

8-K

APVO Aptevo Therapeutics Inc

30 Mar 23

Aptevo Therapeutics Reports 2022 Financial Results and Provides Business Update

7:50am

8-K

APVO Aptevo Therapeutics Inc

30 Mar 23

Entry into a Material Definitive Agreement

7:40am

4

Lamothe Jeffrey G.

7 Mar 23

Aptevo Therapeutics / Jeffrey G. Lamothe ownership change

4:44pm

4

APVO Aptevo Therapeutics Inc

7 Mar 23

Aptevo Therapeutics / SoYoung Kwon ownership change

4:42pm

4

Daphne L Taylor

7 Mar 23

Aptevo Therapeutics / Daphne Taylor ownership change

4:41pm

4/A

APVO Aptevo Therapeutics Inc

7 Mar 23

Aptevo Therapeutics / Daniel Abdun-Nabi ownership change

4:38pm

4

APVO Aptevo Therapeutics Inc

7 Mar 23

Aptevo Therapeutics / Marvin L White ownership change

4:37pm

3

APVO Aptevo Therapeutics Inc

7 Mar 23

Aptevo Therapeutics / Daphne Taylor ownership change

4:30pm

8-K

APVO Aptevo Therapeutics Inc

7 Mar 23

Departure of Directors or Certain Officers

8:15am

SC 13G/A

APVO Aptevo Therapeutics Inc

14 Feb 23

Aptevo Therapeutics / RTW INVESTMENTS ownership change

10:15am

8-K

APVO Aptevo Therapeutics Inc

13 Feb 23

Alligator Bioscience & Aptevo Therapeutics Announce Dosing of First Patient with ALG.APV-527 in Phase 1 Clinical Trial

8:15am

4

APVO Aptevo Therapeutics Inc

30 Jan 23

Aptevo Therapeutics / Marvin L White ownership change

1:07pm

4

Lamothe Jeffrey G.

30 Jan 23

Aptevo Therapeutics / Jeffrey G. Lamothe ownership change

1:04pm

8-K

APVO Aptevo Therapeutics Inc

9 Jan 23

Aptevo Therapeutics Files Provisional Patent for Fifth Bispecific Antibody APVO711, Intended for the Treatment of Solid Tumors

8:15am

8-K

APVO Aptevo Therapeutics Inc

12 Dec 22

Other Events

8:17am

8-K

APVO Aptevo Therapeutics Inc

10 Nov 22

Aptevo Therapeutics Reports Third Quarter 2022 Financial Results and Business Highlights

8:15am

8-K

APVO Aptevo Therapeutics Inc

4 Nov 22

Entry into a Material Definitive Agreement

4:16pm

8-K

APVO Aptevo Therapeutics Inc

19 Sep 22

Alligator Bioscience and Aptevo Therapeutics Announce that FDA has Issued a “May Proceed” Notification for the ALG.APV-527 IND

9:14am